Welcome to our dedicated page for X3 ACQUISITION news (Ticker: XCBEU), a resource for investors and traders seeking the latest updates and insights on X3 ACQUISITION stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect X3 ACQUISITION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of X3 ACQUISITION's position in the market.
X3 Acquisition Corp. Ltd (Nasdaq: XCBEU) said that, effective March 13, 2026, holders of units may elect to separately trade Class A ordinary shares and warrants. Separated shares will trade as XCBE and warrants as XCBEW; unsplit units remain XCBEU.
No fractional warrants will be issued upon separation and only whole warrants will trade. Holders must contact the transfer agent, Continental Stock Transfer & Trust Company, via their brokers to effect separation. A Form S-1 registration (333-290299) was declared effective January 20, 2026.
X3 Acquisition Corp. Ltd (Nasdaq: XCBEU) closed its initial public offering of 20,000,000 units at $10.00 per unit on January 22, 2026, generating aggregate gross proceeds of $200,000,000. Each unit contains one Class A ordinary share and one-half redeemable warrant; whole warrants become exercisable 30 days after the company’s initial business combination at an exercise price of $11.50 per share, subject to adjustment. The units trade on Nasdaq under XCBEU; once separated, shares and warrants are expected to trade as XCBE and XCBEW, respectively. The company intends to use net proceeds and a simultaneous private placement of warrants to pursue a business combination. Stifel acted as underwriter representative; legal counsel and SEC effectiveness dated January 20, 2026 are noted.
X3 Acquisition Corp. Ltd. (NASDAQ: XCBEU) priced an initial public offering of 20,000,000 units at $10.00 per unit, raising gross proceeds of $200,000,000. Units begin trading on January 21, 2026 on Nasdaq under XCBEU and the offering is expected to close on January 22, 2026. Each unit comprises one Class A ordinary share and one-half warrant; whole warrants exercise for one share at $11.50, subject to adjustment. No fractional warrants issued; upon separation shares and warrants are expected to trade as XCBE and XCBEW. Underwriters have a 45-day option to buy up to 3,000,000 additional units for over-allotments. The company is a blank check vehicle targeting business combinations, with an intended focus on financial services.